High doses of prochlorperazine for cisplatin-induced emesis: A prospective, random, dose–response study
✍ Scribed by Brian I. Carr; Douglas W. Blayney; David A. Goldberg; Patricia Braly; Gerald E. Metter; James H. Doroshow
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 446 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Metoclopramide was administered by continuous infusion to two groups each of 14 patients on chemotherapy, randomized to receive either doses adjusted to individual pharmacokinetic parameters or doses adjusted as usual to body weight. The mean plasma concentration at the end of the infusion in the ad
To evaluate the antiemetic effectiveness and toxicity of a novel congener of metoclopramide (MCP), alizapride (AZP), 29 patients receiving cisplatin (50 mg/m2) alone or with adriamycin (40 mg/m2) were entered into a randomized cross-over trial comparing moderate-dose AZP (2 mg/kg for 4 doses) admini